Travere Therapeutics Inc.
TVTX | NASDAQ
$62.86
+$0.10 (+0.16%)
At close: Sep 21, 2026, 4:00 PM ET
$61.12
-$1.74 (-2.77%)
Pre-market:
Sep 22, 2026, 8:46 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 169.58M | 127.2M | 129.69M | 164.86M | 114.45M | 81.73M | 74.79M | 62.9M | 54.12M | 41.37M | 45.06M | 37.1M | 32.2M | 56.99M | 55.87M | 28.08M | 54.17M | 48.49M | 57.25M | 68.22M | 54.62M | 47.41M |
Cost of Revenue | 2.17M | 26.77M | 2.55M | 1.59M | 1.52M | 4.68M | 2.55M | 1.63M | 12.41M | 1.5M | 16.42M | 1.29M | 1.45M | 5.13M | 1.73M | 7.27M | 2.05M | 2.14M | 1.9M | 1.59M | 1.65M | 1.65M |
Gross Profit | 167.41M | 100.43M | 127.14M | 163.27M | 112.93M | 77.05M | 72.23M | 61.27M | 41.71M | 39.87M | 28.64M | 35.81M | 30.74M | 51.87M | 54.14M | 20.81M | 52.12M | 46.35M | 55.35M | 66.63M | 52.97M | 45.76M |
Operating Income | 3.95M | -36.92M | -32.43M | 24.93M | -12.65M | -42.67M | -60.74M | -56.15M | -67.05M | -139.24M | -82.84M | -92.59M | -103.95M | -80.29M | -66.85M | -82.6M | -65.45M | -57.05M | -47.19M | -31.71M | -35.32M | -47.55M |
Interest Income | 3.36M | 2.58M | 2.59M | 3.05M | 3.29M | 3.8M | 3.8M | 3.57M | 4.42M | 6.03M | 7.15M | 5.84M | 5.13M | 3.65M | 3.12M | 2.1M | 782K | 278K | 236K | 360K | 988K | 409K |
Pretax Income | -35M | -36.72M | -21.07M | 25.71M | -12.74M | -41.19M | -60.34M | -54.84M | -69.57M | -135.77M | -88.53M | -89.23M | -101.87M | -96.49M | -65.76M | -83.92M | -66.98M | -75.92M | -51.57M | -35.6M | -38.96M | -53.55M |
Net Income | -34.8M | -37.1M | 2.73M | 25.71M | -12.76M | -41.23M | -60.26M | -54.81M | -70.41M | -136.06M | -90.17M | 150.74M | -85.63M | -86.33M | -65.82M | -69.66M | -67.03M | -75.97M | -51.57M | -35.64M | -39.01M | -53.87M |
Selling & General & Admin | 96.11M | 80.25M | 101.69M | 86.45M | 76.22M | 72.84M | 69.5M | 65.62M | 54.43M | 64.22M | 52.73M | 67.8M | 68.2M | 72.25M | 62.92M | 52.42M | 52.98M | 46.79M | 42.08M | 36.07M | 34.97M | 36.78M |
Research & Development | 60.28M | 57.09M | 57.87M | 51.89M | 49.36M | 46.89M | 62.07M | 51.68M | 54.33M | 114.63M | 58.75M | 60.59M | 66.49M | 59.91M | 60.23M | 57.15M | 59.68M | 56.61M | 62.17M | 48.41M | 51.81M | 47.95M |
Other Expenses | 7.06M | n/a | n/a | n/a | n/a | n/a | 1.4M | 123K | n/a | 259K | n/a | n/a | n/a | 87K | -2.16M | -6.15M | 4.91M | 26K | -1.7M | 13.86M | 1.51M | 8.59M |
Operating Expenses | 163.46M | 137.35M | 159.56M | 138.34M | 125.58M | 119.73M | 132.97M | 117.42M | 108.76M | 179.11M | 111.48M | 128.39M | 134.7M | 132.16M | 120.99M | 103.41M | 117.57M | 103.4M | 102.54M | 98.34M | 88.28M | 93.31M |
Interest Expense | 2.13M | 2.3M | 2.3M | 2.75M | 2.85M | 2.86M | 2.82M | 2.78M | 2.79M | 2.8M | 2.82M | 2.82M | 2.84M | 2.85M | 2.9M | 2.83M | 2.97M | 2.52M | 5.07M | 4.9M | 4.85M | 5.32M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.35M | n/a | -10.86M | n/a | n/a | 6.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 165.63M | 164.11M | 162.12M | 139.93M | 127.1M | 124.41M | 135.52M | 119.05M | 121.17M | 180.35M | 127.9M | 129.68M | 136.15M | 137.28M | 122.72M | 110.68M | 119.62M | 105.54M | 104.44M | 99.93M | 89.93M | 94.96M |
Income Tax Expense | -204K | -120K | 921K | 8K | 20K | 39K | -72K | -84K | 85K | 191K | 68K | 12K | 65K | 78K | 63K | 145K | 53K | 52K | 4K | 43K | 49K | 313K |
Shares Outstanding (Basic) | 93.48M | 91.87M | 90.29M | 89.23M | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.41M | 60.57M | 56.27M |
Shares Outstanding (Diluted) | 93.48M | 91.87M | 90.29M | 102.62M | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.8M | 60.57M | 56.27M |
EPS (Basic) | -0.37 | -0.40 | 0.03 | 0.29 | -0.14 | -0.47 | -0.73 | -0.70 | -0.91 | -1.76 | -1.18 | -0.99 | -1.13 | -1.27 | -1.03 | -1.09 | -1.05 | -1.20 | -0.84 | -0.59 | -0.64 | -0.96 |
EPS (Diluted) | -0.37 | -0.40 | 0.03 | 0.25 | -0.14 | -0.47 | -0.73 | -0.70 | -0.91 | -1.76 | -1.18 | -0.99 | -1.13 | -1.27 | -1.03 | -1.09 | -1.05 | -1.20 | -0.84 | -0.59 | -0.64 | -0.96 |
EBITDA | -32.87M | -9.21M | -632K | 44.25M | 4.13M | -25.53M | -45.43M | -40.82M | -56.43M | -123.09M | -73.86M | -74.93M | -88.08M | -84.09M | -53.56M | -74.94M | -55.9M | -66.31M | -40.45M | -22.82M | -27.49M | -42.16M |
EBIT | -32.87M | -34.42M | -18.77M | 28.47M | -9.89M | -38.33M | -57.52M | -52.06M | -66.78M | -132.97M | -85.71M | -86.41M | -99.02M | -93.64M | -62.86M | -81.09M | -64.01M | -73.4M | -46.5M | -30.7M | -34.11M | -48.23M |
Depreciation & Amortization | n/a | 25.21M | 18.14M | 15.79M | 14.02M | 12.8M | 12.09M | 11.24M | 10.35M | 9.88M | 11.85M | 11.48M | 10.95M | 9.55M | 9.3M | 6.15M | 8.11M | 7.09M | 6.05M | 7.87M | 6.62M | 6.07M |
Add to Watchlist
Select watchlists to add or remove TVTX